GLIKNIK
Gliknik, Inc., a biopharmaceuticals company, develops therapies for patients with cancer and immune disorders. Its Immunomodulator Platform involves in off-the-shelf peptide drugs that increase CD4, CD8, and antibody immune responses against cancer; Stradomer Platform produces drugs designed to mimic the eficacy of pooled human intravenous immunoglobulin; and Stradobody Platform produces compounds that are similar to moncolonal antibodies for tumor cell killing. The company was founded in 2007 and is based in Baltimore, Maryland.
GLIKNIK
Industry:
Biotechnology Health Care Medical
Founded:
2007-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.gliknik.com
Total Employee:
51+
Status:
Active
Contact:
(410) 685-0662
Total Funding:
70.06 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics WordPress Domain Not Resolving Apache Sitelinks Search Box
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Praxis Precision Medicines
Praxis Precision Medicines offers drug development services.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
RDA Ventures
RDA Ventures investment in Series C - Gliknik
First In Ventures
First In Ventures investment in Series C - Gliknik
Pfizer
Pfizer investment in Corporate Round - Gliknik
Baxter International
Baxter International investment in Series B - Gliknik
Joel B. Braunstein
Joel B. Braunstein investment in Venture Round - Gliknik
Official Site Inspections
http://www.gliknik.com Semrush global rank: 4.44 M Semrush visits lastest month: 2.49 K
- Host name: 215.115.180.107.host.secureserver.net
- IP address: 107.180.115.215
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260